| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,327 |
4,068 |
$215K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,470 |
3,245 |
$170K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
582 |
535 |
$53K |
| 64493 |
|
333 |
312 |
$27K |
| 99443 |
|
231 |
206 |
$17K |
| 64494 |
|
319 |
298 |
$13K |
| 62323 |
|
64 |
59 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
358 |
354 |
$5K |
| 99442 |
|
55 |
55 |
$3K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
269 |
253 |
$901.35 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13 |
13 |
$377.67 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
128 |
116 |
$214.48 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
14 |
14 |
$142.34 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
242 |
222 |
$0.00 |